Document is current
Any future updates will be listed below
-
Authors
Liu, Xin https://orcid.org/0000-0002-9622-672X
Sun, Tao
Shcherbina, Anna
Li, Qin https://orcid.org/0000-0002-8948-2717
Jarmoskaite, Inga https://orcid.org/0000-0001-5847-5867
Kappel, Kalli https://orcid.org/0000-0002-2129-199X
Ramaswami, Gokul
Das, Rhiju https://orcid.org/0000-0001-7497-0972
Kundaje, Anshul https://orcid.org/0000-0003-3084-2287
Li, Jin Billy https://orcid.org/0000-0003-0713-1399
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM124215, GM102484)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 25 November 2019
Accepted: 15 March 2021
First Online: 12 April 2021
Competing interests
: The authors declare the following competing interests: J.B.L. is a co-founder of AIRNA Bio and a consultant for Risen Pharma. Anna Shcherbina receives consulting fees from Myokardia, Inc, is a scientific adviser to Ravel Bio, Inc., and an employee of Insitro, Inc.
